DeepLook Medical has recently achieved a significant milestone by receiving regulatory approval in the United Kingdom for its DL Precise software. DL Precise, an advanced visual enhancement software, distinguishes itself through its ability to uncover hidden data within medical images. Utilizing a sophisticated shape-recognition technique, the software provides clear, segmented, and measured views of target masses, enhancing the speed, accuracy, and consistency of medical imaging analysis.
“We are thrilled to announce the UK regulatory clearance for DL Precise,” said Marissa Fayer, CEO of DeepLook Medical. “This clearance validates the transformative potential of our software in enhancing workflow efficiency and improving reporting precision for healthcare providers across the UK.”
DL Precise’s innovative features include one-click activation, which streamlines the segmentation process and eliminates the need for complex manual setup. The software instantly renders segmentation by contouring an object’s margins and measures long and short dimension axes, area, and estimated volume. Users retain full control and can modify automated measurements as needed, ensuring flexibility and accuracy.
“DL Precise represents a paradigm shift in medical imaging technology,” said Dr. Charlotte Moser, Chief Medical Officer of DeepLook Medical. “By providing consistent, accurate measurements across all imaging modalities, DL Precise empowers radiologists to make informed decisions with confidence, ultimately enhancing patient care.”
The technology behind DL Precise is patented and forms the foundation for future products that will utilize radiomic data to offer essential metrics and bolster AI/machine learning applications in medical imaging. Through a partnership with Barco, DeepLook’s technology will be accessible across the UK, specifically aiming to offer women with dense breasts more accurate diagnostics and improved care options.
